Published in Drug Week, December 21st, 2007
"Of patients with higher than median (high) OCT-1 activity, 85% achieved major molecular...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.